Innate Pharma Financial Overview
Innate Pharma's market cap is currently $165.60M. The company's EPS TTM is $-0.296; its P/E ratio is -2.93; Innate Pharma is scheduled to report earnings on September 17, 2025, and the estimated EPS forecast is $-0.14. See an overview of income statement, balance sheet, and cash flow financials.
